Raza Syed Tasleem, Abbas Shania, Siddiqi Zeba, Mahdi Farzana
Department of Biochemistry, Era's Lucknow Medical College and Hospital, Lucknow, India.
Department of Medicine Era's Lucknow Medical College and Hospital, Lucknow, India.
Int J Mol Cell Med. 2017 Spring;6(2):121-130. doi: 10.22088/acadpub.BUMS.6.2.6. Epub 2017 Jul 4.
Diabetic dyslipidemia is one of the leading causes of coronary artery disease (CAD) death. Genetic and environmental factors play an important role in the development of type 2 diabetes mellitus (T2DM) and dyslipidemia. The present study was aimed to investigate the association of (rs4646994), (rs1799883), (rs1801133) and (rs9939609) genes polymorphism in T2DM with dyslipidemia. Totally, 559 subjects including 221 T2DM cases with dyslipidemia, 158 T2DM without dyslipidemia and 180 controls were enrolled. genes polymorphism was evaluated by polymerase chain reaction (PCR), while , , genes polymorphisms were evaluated by PCR and restriction fragment length polymorphism (RFLP). Significant association of and genes polymorphisms were found in both group of cases [T2DM with dyslipidemia (P<0.001, and P=0.008, respectively) and T2DM without dyslipidemia (P=0.003, and P=0.010, respectively)] while and genes polymorphisms were significantly associated with T2DM without dyslipidemia (P=0.038, and P= 0.019, respectively). This study concludes that , , and genes are associated with T2DM. Additionally, it also seems that and genes might be further associated with the development of dyslipidemia in T2DM cases.
糖尿病血脂异常是冠状动脉疾病(CAD)死亡的主要原因之一。遗传和环境因素在2型糖尿病(T2DM)和血脂异常的发生发展中起重要作用。本研究旨在探讨T2DM中(rs4646994)、(rs1799883)、(rs1801133)和(rs9939609)基因多态性与血脂异常的相关性。共纳入559名受试者,包括221例伴有血脂异常的T2DM患者、158例无血脂异常的T2DM患者和180名对照者。采用聚合酶链反应(PCR)评估基因多态性,而采用PCR和限制性片段长度多态性(RFLP)评估、、基因多态性。在两组病例中均发现和基因多态性存在显著相关性[T2DM伴血脂异常组(分别为P<0.001和P=0.008)和无血脂异常的T2DM组(分别为P=0.003和P=0.010)],而和基因多态性与无血脂异常的T2DM显著相关(分别为P=0.038和P=0.019)。本研究得出结论,、、和基因与T2DM相关。此外,似乎和基因可能进一步与T2DM病例中血脂异常的发生相关。